Fig. 4
From: Childhood Takayasu arteritis: disease course and response to therapy
Flare-free survival in the 22 childhood TAK patients with active disease at diagnosis. a Flare-free survival separated into different treatment groups (biologics N = 12; cyclophosphamide N = 10; corticosteroids only N = 4; methotrexate/azathioprine/mycophenolate mofetil/leflunomide N = 30 treatment episodes), adjusted for the number of treatment episodes. b Flare-free survival grouped into biologic therapy (N = 12 treatment episodes) and non-biologic therapy (methotrexate, azathioprine, mycophenolate mofetil, leflunomide, corticosteroids, cyclophosphamide, N = 44 treatment episodes), adjusted for the number of treatment episodes